Point of Care Testing Market Development Data, Industry Trends and Forecast to 2030

I am mayuripuranik57. I hold full responsibility for this content, which includes text, images, links, and files. The website administrator and team cannot be held accountable for this content. If there is anything you need to discuss, you can reach out to me via mayuripuranik57@gmail.com email.

Delvens is the leading strategic advisory data provider and consulting company. We help companies understand what other players are doing.
Point of Care Testing Market Development Data, Industry Trends and Forecast to 2030
Point of Care Testing Market by Product (Glucose testing , HIV testing, Hepatitis C testing, Pregnancy testing), Platform (Microfluidics, Dipstick, Immunoassay), Purchase (OTC, Prescription), Sample (Blood, Urine), End User (Pharmacy, Hospital, Homecare) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Delvens has released a new research study titled "Point of Care Testing Market" analysis by the following subjects: Industry size, share, growth, segmentation, manufacturers and innovations, major trends, market drivers, restraints, regulations, distribution methods, opportunities, strategies, prospective road maps, and yearly forecast till 2030. The purpose of the market research study is to thoroughly investigate the industry in order to gain knowledge of the industry and its economic potential. report also looks at SWOT and Porter's Five Forces Analysis, as well as crucial statistics like expenditure, costs, revenue, and end-clients.

Global Point of Care Testing Market size was estimated at USD 39.1 billion in 2023 and is projected to reach USD 78.48 billion in 2030 at a CAGR of 9.1% during the forecast period 2023-2030.

Get Free Sample Report@ https://www.delvens.com/get-free-sample/point-of-care-testing-market

Point-of-care testing, often abbreviated as POCT, is a term that refers to medical diagnostic testing conducted in close proximity to the patient. This type of testing is designed to facilitate immediate medical decisions based on the results and ongoing monitoring of the patient's condition.

The primary advantage of point-of-care testing is its ability to expedite patient care. By providing real-time results, it ensures that patients receive the most effective and efficient care possible, right when they need it.

Top Key Competitors of Point of Care Testing Market:

·        Abbott (U.S.)

·        F. Hoffmann-La Roche Ltd (Switzerland)

·        BD (U.S.)

·        Siemens Healthcare Private Limited (Germany)

·        Bio-Rad Laboratories, Inc. (U.S.)

·        Danaher (U.S.)

·        Sekisui Diagnostics (U.S.)

·        Trinity Biotech (Ireland)

·        bioMérieux (France)

·        EKF Diagnostics (Germany)

·        AccuBioTech Co., Ltd. (China)

·        Instrumentation Laboratory (U.S.)

·        Beckman Coulter, Inc. (U.S.)

·        PTS Diagnostics (U.S.)

·        Nova Biomedical (U.S.)

·        Chembio Diagnostics, Inc. (U.S.)

·        Quidel Corporation (U.S.)

·        Sienco, Inc (U.S.) and More

For More Inquiry Contact us@ https://www.delvens.com/Inquire-before-buying/point-of-care-testing-market

Recent Developments

·        In July 2022, QuantuMDx announced the launch of its new respiratory panel test; Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay.

·        In July 2022, Boditech Med entered in strategic partnership with Novo Integrated Sciences, Inc. with an aim to expand its biomarker based rapid testing product line across North America.

Table of Contents:

The Point of Care Testing Market is segmented into various segments such as Product, Platform, Purchase, Sample, End User and region:

·        Based on Product

·        Based on the Platform

·        Based on the Sample

·        Based on End User

·        Based on region

Access Full Report@ https://www.delvens.com/report/point-of-care-testing-market

More Reports from Delvens:

Assisted Living (AL) Market size was estimated at USD 180.70 billion in 2023 and is projected to reach USD 305.70 billion in 2030 at a CAGR of 7.8% during the forecast period 2023-2030.

Congenital Heart Disease (CHD) market size was estimated at USD 4.47 billion in 2023 and is projected to reach USD 8.11 billion in 2030 at a CAGR of 8.87% during the forecast period 2023-2030.

Periodontal Disease Treatment market size was estimated at USD 799.17 million in 2023 and is projected to reach USD 1438.54 million in 2030 at a CAGR of 8.76% during the forecast period 2023-2030.

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-3290-6466

+1 214-377-1144

sales@delvens.com

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations